RVNC RSI Chart
Last 7 days
14.1%
Last 30 days
-8.3%
Last 90 days
-27.2%
Trailing 12 Months
-88.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 236.6M | 0 | 0 | 0 |
2023 | 156.6M | 186.4M | 214.2M | 234.0M |
2022 | 89.8M | 99.3M | 108.6M | 132.6M |
2021 | 28.6M | 47.1M | 63.0M | 77.8M |
2020 | 4.1M | 7.9M | 11.6M | 15.3M |
2019 | 4.3M | 4.8M | 5.1M | 413.0K |
2018 | 2.4M | 3.1M | 4.0M | 3.7M |
2017 | 1.2M | 1.2M | 963.0K | 1.7M |
2016 | 502.0K | 777.0K | 1.0M | 1.2M |
2015 | 252.0K | 226.0K | 219.0K | 219.0K |
2014 | 700.0K | 700.0K | 617.0K | 383.0K |
2013 | 266.8K | 383.5K | 500.3K | 617.0K |
2012 | 0 | 0 | 0 | 150.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 01, 2024 | ware olivia c | acquired | - | - | 15,000 | - |
May 01, 2024 | russell angus c. | acquired | - | - | 15,000 | - |
May 01, 2024 | beraud jill | acquired | - | - | 15,000 | - |
May 01, 2024 | nolet chris | acquired | - | - | 15,000 | - |
May 01, 2024 | kolaja carey oconnor | acquired | - | - | 15,000 | - |
May 01, 2024 | coric vlad | acquired | - | - | 15,000 | - |
May 01, 2024 | gangolli julian s | acquired | - | - | 15,000 | - |
Apr 16, 2024 | jordan erica | sold | -9,096 | 3.8028 | -2,392 | chief commercial officer |
Mar 18, 2024 | moxie dwight | sold | -40,971 | 5.0426 | -8,125 | clo & gc |
Mar 18, 2024 | schilke tobin | sold | -47,203 | 5.0426 | -9,361 | cfo |
Which funds bought or sold RVNC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 08, 2024 | ProShare Advisors LLC | added | 9.00 | -68,868 | 107,767 | -% |
May 08, 2024 | PROFUND ADVISORS LLC | reduced | -41.15 | -227,491 | 111,733 | -% |
May 08, 2024 | Summit X, LLC | added | 92.28 | 11,704 | 164,523 | 0.04% |
May 08, 2024 | GREAT LAKES ADVISORS, LLC | sold off | -100 | -2,056,490 | - | -% |
May 08, 2024 | Entropy Technologies, LP | sold off | -100 | -193,362 | - | -% |
May 08, 2024 | Russell Investments Group, Ltd. | new | - | 822 | 822 | -% |
May 08, 2024 | US BANCORP \DE\ | added | 23.59 | -6,581 | 14,770 | -% |
May 08, 2024 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | reduced | -1.81 | 543,803 | 753,102 | -% |
May 07, 2024 | SEI INVESTMENTS CO | reduced | -77.56 | -497,923 | 71,499 | -% |
May 07, 2024 | ASSETMARK, INC | reduced | -96.68 | -17,649 | 335 | -% |
Unveiling Revance Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Revance Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 47.0B | 6.8B | -7.88 | 6.87 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.2B | 2.0B | -57.69 | 9.56 | ||||
BMRN | 15.5B | 2.5B | 75.54 | 6.28 | ||||
INCY | 12.0B | 3.8B | 16.12 | 3.19 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.84 | 48.09 | ||||
APLS | 5.2B | 524.1M | -12.38 | 9.86 | ||||
AXSM | 3.5B | 251.0M | -11.8 | 13.94 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.5K | 3.08 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 28.42 | 4.5 | ||||
NVAX | 627.0M | 983.7M | -1.15 | 0.64 | ||||
CRBP | 467.5M | 881.7K | -13.85 | 481.06 | ||||
INO | 260.8M | 4.9M | -1.93 | 53.59 | ||||
IBIO | 6.4M | 2.1M | -0.24 | 2.14 |
Revance Therapeutics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -25.6% | 51,936,000 | 69,799,000 | 56,776,000 | 58,134,000 | 49,331,000 | 49,921,000 | 29,015,000 | 28,368,000 | 25,261,000 | 25,950,000 | 19,745,000 | 18,804,000 | 13,299,000 | 11,133,000 | 3,835,000 | 299,000 | 58,000 | 693,500 | 1,329,000 | 1,596,000 | 1,570,000 |
Operating Expenses | -20.2% | 98,763,000 | 123,752,000 | 196,069,000 | 123,633,000 | 107,363,000 | 194,332,000 | 106,499,000 | 86,210,000 | 87,482,000 | 87,554,000 | 92,468,000 | 89,141,000 | 83,311,000 | 89,102,000 | 80,963,000 | 57,404,000 | 61,018,000 | 46,259,000 | 42,586,000 | 39,122,000 | 36,905,000 |
S&GA Expenses | -19.2% | 68,914,000 | 85,243,000 | 69,094,000 | 77,384,000 | 66,011,000 | 65,237,000 | 65,775,000 | 47,847,000 | 45,075,000 | 46,436,000 | 52,782,000 | 50,598,000 | 49,005,000 | 52,833,000 | 48,183,000 | 29,606,000 | 21,224,000 | 18,766,000 | 16,739,000 | 13,596,000 | 12,910,000 |
R&D Expenses | -29.3% | 14,393,000 | 20,366,000 | 13,060,000 | 22,807,000 | 23,177,000 | 19,541,000 | 26,103,000 | 24,913,000 | 30,729,000 | 29,468,000 | 30,095,000 | 29,441,000 | 27,251,000 | 29,768,000 | 29,130,000 | 27,103,000 | 39,794,000 | 27,493,000 | 25,847,000 | 25,526,000 | 23,995,000 |
EBITDA Margin | - | - | - | - | - | - | - | - | -2.69 | -3.01 | -3.49 | -4.19 | - | -9.37 | -19.55 | -30.54 | -22.93 | -21.17 | -21.27 | -22.31 | -18.66 | - |
Interest Expenses | -2.6% | 5,256,000 | 5,398,000 | 5,093,000 | 4,368,000 | 4,497,000 | 3,752,000 | 6,917,000 | 3,874,000 | 1,931,000 | 1,573,000 | 1,571,000 | 1,569,000 | 1,560,000 | 4,410,000 | 4,334,000 | 4,256,000 | 2,148,000 | - | - | - | - |
Income Taxes | - | - | - | 300,000 | - | - | - | 700,000 | - | - | - | - | - | - | -2,720,000 | - | - | 100,000 | - | - | - | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | - | -74,376,000 | - | - | - | -81,257,000 | - | - | - | - | - | - |
EBT Margin | - | - | - | - | - | - | - | - | -3.00 | -3.31 | -3.82 | -4.63 | - | -10.27 | -21.21 | -32.27 | -25.01 | -22.11 | -21.80 | -22.86 | -19.11 | - |
Net Income | 4.5% | -53,200,000 | -55,699,000 | -141,176,000 | -67,318,000 | -59,793,000 | -145,952,000 | -84,693,000 | -61,435,000 | -64,342,000 | -63,098,000 | -74,376,000 | -72,197,000 | -71,639,000 | -78,309,000 | -81,257,000 | -60,590,000 | -61,933,000 | -45,326,000 | -41,409,000 | -37,390,000 | -35,304,000 |
Net Income Margin | 3.1% | -1.34 | -1.38 | -1.93 | -1.92 | -2.25 | -2.69 | -2.52 | -2.65 | -3.05 | -3.62 | -4.71 | -6.45 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -52.0% | -67,651,000 | -44,510,000 | -55,465,000 | -53,116,000 | -70,370,000 | -31,470,000 | -58,873,000 | -43,689,000 | -62,726,000 | -48,968,000 | -54,169,000 | -49,985,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 6.2% | 508 | 478 | 532 | 598 | 548 | 582 | 712 | 562 | 640 | 531 | 582 | 641 | 676 | 720 | 712 | 576 | 593 | 340 | 266 | 296 | 324 |
Current Assets | 9.1% | 370 | 339 | 389 | 379 | 323 | 375 | 416 | 261 | 285 | 246 | 294 | 355 | 406 | 450 | 450 | 503 | 518 | 297 | 221 | 250 | 277 |
Cash Equivalents | 1.9% | 140 | 137 | 179 | 141 | 137 | 109 | 110 | 75.00 | 204 | 116 | 132 | 171 | 253 | 337 | 341 | 365 | 287 | 172 | 60.00 | 91.00 | 66.00 |
Inventory | 10.3% | 50.00 | 46.00 | 46.00 | 34.00 | 28.00 | 18.00 | 17.00 | 14.00 | 11.00 | 10.00 | 10.00 | 5.00 | 6.00 | 6.00 | 4.00 | 1.00 | - | - | - | - | - |
Net PPE | 1.6% | 18.00 | 17.00 | 17.00 | 13.00 | 14.00 | 14.00 | 23.00 | 23.00 | 23.00 | 25.00 | 22.00 | 21.00 | 21.00 | 17.00 | 15.00 | 14.00 | 14.00 | 15.00 | 15.00 | 15.00 | 15.00 |
Goodwill | - | - | - | - | 77.00 | 77.00 | 77.00 | 147 | 147 | 147 | 147 | 147 | 147 | 147 | 147 | 145 | - | - | - | - | - | - |
Liabilities | -3.7% | 607 | 630 | 639 | 571 | 574 | 569 | 566 | 565 | 614 | 463 | 462 | 455 | 432 | 346 | 339 | 320 | 285 | 115 | 115 | 107 | 103 |
Current Liabilities | -22.8% | 69.00 | 89.00 | 82.00 | 74.00 | 78.00 | 76.00 | 75.00 | 77.00 | 71.00 | 67.00 | 66.00 | 58.00 | 51.00 | 61.00 | 64.00 | 48.00 | 42.00 | 41.00 | 34.00 | 45.00 | 34.00 |
Long Term Debt | -0.4% | 425 | 427 | 427 | 380 | 380 | 379 | 379 | 378 | 90.00 | 281 | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Current | 100.0% | 5.00 | 3.00 | 1.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 427 | 427 | - | - | 379 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 34.9% | -98.67 | -151 | - | 27.00 | -26.67 | 13.00 | 146 | 0.00 | 26.00 | 68.00 | 120 | 1,447 | 244 | 374 | 373 | 0.00 | 0.00 | 225 | 151 | 0.00 | 221 |
Retained Earnings | -2.6% | -2,131 | -2,078 | -2,000 | -1,881 | -1,814 | -1,754 | -1,600 | -1,500 | -1,500 | -1,397 | -1,334 | -1,260 | -1,200 | -1,126 | -1,050 | -966 | -906 | -844 | -798 | -757 | -720 |
Additional Paid-In Capital | 5.5% | 2,033 | 1,927 | 1,916 | 1,908 | 1,788 | 1,767 | 1,755 | 1,521 | 1,488 | 1,466 | 1,455 | 1,447 | 1,432 | 1,501 | 1,421 | 1,222 | 1,214 | 1,070 | 950 | 946 | 941 |
Shares Outstanding | 18.7% | 104 | 88.00 | 88.00 | 88.00 | 84.00 | 82.00 | 82.00 | 73.00 | 72.00 | 68.00 | 72.00 | 72.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 2,200 | - | - | - | 1,000 | - | - | - | 2,000 | - | - | - | 1,400 | - | - | - | 494 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -54.3% | -65,939 | -42,731 | -50,962 | -53,382 | -69,500 | -30,182 | -57,871 | -44,225 | -61,270 | -44,611 | -53,167 | -49,005 | -74,755 | -62,314 | -55,686 | -17,213 | -43,289 | -33,508 | -31,949 | -29,290 | -11,414 |
Share Based Compensation | 1.6% | 8,990 | 8,845 | 10,287 | 15,599 | 13,082 | 10,727 | 17,987 | 9,263 | 14,363 | 10,921 | 10,538 | 11,368 | 10,607 | 11,879 | 10,677 | 7,353 | 6,544 | 5,040 | 4,303 | 4,420 | 4,159 |
Cashflow From Investing | -1437.9% | -31,709 | 2,370 | 51,586 | -39,532 | 95,316 | 40,960 | -118,445 | -105,881 | 44,568 | 27,641 | 16,807 | -35,693 | -38,420 | -8,691 | 32,496 | 93,895 | -105,569 | 30,919 | 918 | 54,012 | -103,441 |
Cashflow From Financing | 5798.5% | 92,828 | -1,629 | 37,460 | 97,471 | 3,265 | -6,173 | 211,389 | 21,165 | 105,313 | 405 | -2,492 | 2,912 | 29,044 | 67,324 | -687 | 500 | 264,347 | 114,827 | -81.00 | 43.00 | 106,868 |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue: | |||
Total revenue | $ 234,040 | $ 132,565 | $ 77,798 |
Operating expenses: | |||
Selling, general and administrative | 297,732 | 223,934 | 198,821 |
Research and development | 79,410 | 101,286 | 116,255 |
Goodwill impairment | 77,175 | 69,789 | 0 |
Intangible asset impairment | 16,007 | 0 | 0 |
Amortization | 6,130 | 27,847 | 13,988 |
Total operating expenses | 550,817 | 474,523 | 352,474 |
Loss from operations | (316,777) | (341,958) | (274,676) |
Interest income | 13,285 | 4,891 | 337 |
Interest expense | (19,356) | (16,474) | (6,273) |
Other expense, net | (838) | (2,181) | (698) |
Loss before income taxes | (323,686) | (355,722) | (281,310) |
Income tax provision | (300) | (700) | 0 |
Net loss | (323,986) | (356,422) | (281,310) |
Unrealized gain (loss) | 388 | (356) | (18) |
Comprehensive loss | (323,598) | (356,778) | (281,328) |
Basic net loss | (323,986) | (356,422) | (281,310) |
Diluted net loss | $ (323,986) | $ (356,422) | $ (281,310) |
Basic net loss per share (in dollars per share) | $ (3.83) | $ (4.90) | $ (4.17) |
Diluted net loss per share (in dollars per share) | $ (3.83) | $ (4.90) | $ (4.17) |
Basic weighted-average number of shares used in computing net loss per share (in shares) | 84,599,409 | 72,713,340 | 67,507,818 |
Diluted weighted-average number of shares used in computing net loss per share (in shares) | 84,599,409 | 72,713,340 | 67,507,818 |
Product revenue | |||
Revenue: | |||
Total revenue | $ 212,658 | $ 118,131 | $ 70,820 |
Operating expenses: | |||
Cost of product revenue /service revenue (exclusive of depreciation and amortization) | 62,335 | 44,414 | 23,125 |
Service revenue | |||
Revenue: | |||
Total revenue | 12,249 | 6,990 | 1,323 |
Operating expenses: | |||
Cost of product revenue /service revenue (exclusive of depreciation and amortization) | 12,028 | 7,253 | 285 |
Collaboration revenue | |||
Revenue: | |||
Total revenue | $ 9,133 | $ 7,444 | $ 5,655 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
CURRENT ASSETS | ||
Cash and cash equivalents | $ 137,329 | $ 108,965 |
Restricted cash, current | 550 | 0 |
Short-term investments | 116,586 | 231,742 |
Accounts receivable, net | 27,676 | 11,339 |
Inventories | 45,579 | 18,325 |
Prepaid expenses and other current assets | 11,145 | 4,356 |
Total current assets | 338,865 | 374,727 |
Property and equipment, net | 17,225 | 13,799 |
Goodwill | 0 | 77,175 |
Intangible assets, net | 9,808 | 35,344 |
Operating lease right-of-use assets | 53,167 | 39,223 |
Finance lease right-of-use asset | 19,815 | 6,393 |
Restricted cash, non-current | 6,870 | 6,052 |
Finance lease prepaid expense | 32,383 | 27,500 |
Other non-current assets | 321 | 1,687 |
TOTAL ASSETS | 478,454 | 581,900 |
CURRENT LIABILITIES | ||
Accounts payable | 13,809 | 4,546 |
Accruals and other current liabilities | 53,824 | 59,357 |
Deferred revenue, current | 10,737 | 6,867 |
Finance lease liability, current | 2,651 | 669 |
Operating lease liabilities, current | 5,703 | 4,243 |
Debt, current | 2,500 | 0 |
Total current liabilities | 89,224 | 75,682 |
Debt, non-current | 426,595 | 379,374 |
Deferred revenue, non-current | 70,419 | 78,577 |
Operating lease liabilities, non-current | 40,985 | 34,182 |
Other non-current liabilities | 2,835 | 1,485 |
TOTAL LIABILITIES | 630,058 | 569,300 |
Commitments and Contingencies (Note 15) | ||
STOCKHOLDERS’ EQUITY (DEFICIT) | ||
Preferred stock, par value $0.001 per share — 5,000,000 shares authorized, and no shares issued and outstanding as of December 31, 2023 and 2022 | 0 | 0 |
Common stock, par value $0.001 per share — 190,000,000 shares authorized as of December 31, 2023 and 2022; 87,962,765 and 82,385,810 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 88 | 82 |
Additional paid-in capital | 1,926,654 | 1,767,266 |
Accumulated other comprehensive gain (loss) | 14 | (374) |
Accumulated deficit | (2,078,360) | (1,754,374) |
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) | (151,604) | 12,600 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $ 478,454 | $ 581,900 |
 | Mr. Mark J. Foley |
---|---|
 | revance.com |
 | Biotechnology |
 | 534 |